# Effects of Deep Regional Hyperthermia in Patients With Anal Carcinoma Treated by Standard Radiochemotherapy

> **NCT02369939** · PHASE3 · UNKNOWN · sponsor: **University of Erlangen-Nürnberg Medical School** · enrollment: 118 (estimated)

## Conditions studied

- Anal Carcinoma

## Interventions

- **RADIATION:** Irradiation
- **DRUG:** Mitomycin C
- **DRUG:** 5-Fluorouracil
- **PROCEDURE:** Hyperthermia

## Key facts

- **NCT ID:** NCT02369939
- **Lead sponsor:** University of Erlangen-Nürnberg Medical School
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-12
- **Primary completion:** 2017-12
- **Final completion:** 2021-04
- **Target enrollment:** 118 (ESTIMATED)
- **Last updated:** 2017-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02369939

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02369939, "Effects of Deep Regional Hyperthermia in Patients With Anal Carcinoma Treated by Standard Radiochemotherapy". Retrieved via AI Analytics 2026-09-26 from https://api.ai-analytics.org/clinical/NCT02369939. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*